J. Hsu

Oncology · Molecules and Cells · 2016–2020

A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Oncology — 77 citations into it
• Immunology — 69 citations into it

Whom J. Hsu trusts

Their strongest outbound trust, strongest first, inferred from their citations.

1. Lieping Chen (in Immunology)

Papers from J. Hsu's perspective

Ordered by how strongly the researchers J. Hsu trusts endorse each paper. Same corpus, a different order for every researcher.

1. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma (Nature Medicine)
2. The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
3. Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity (Nature Medicine)
4. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
5. Programmed death ligand-1 expression in non-small cell lung cancer (Laboratory Investigation)
6. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. (Proceedings of the National Academy of Sciences of the United States of America)
7. Nivolumab in previously untreated melanoma without BRAF mutation. (New England Journal of Medicine)
8. Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production 1 (Journal of Immunology)
9. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. (New England Journal of Medicine)
10. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion (Nature Medicine)

Their papers

• PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression (2017) — 857 citations
• PD-L1-Mediated Gasdermin C Expression Switches Apoptosis to Pyroptosis in Cancer Cells and Facilitates Tumor Necrosis (2020) — 807 citations
• Mechanisms controlling PD-L1 expression in cancer (2019) — 898 citations
• Metformin promotes antitumor immunity via endoplasmic reticulum-associated degradation of PD-L1 (2018) — 690 citations
• Deubiquitination and Stabilization of PD-L1 by CSN5 (2016) — 727 citations
• Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity (2016) — 993 citations